Literature DB >> 2177732

Hydroxyapatite ceramic as a bone substitute.

U Heise1, J F Osborn, F Duwe.   

Abstract

We have used hydroxyapatite ceramic as a bone substitute for grafting in extensive bone replacement. Hydroxyapatite is composed of calcium phosphate and is incorporated into bone as a physiological mineral. It is not antigenic, carcinogenic or osteogenic. The material used in this study differs from other hydroxyapatite ceramics in that it is an interconnected porous system. Between 1981 and 1986 we used this material on forty five occasions in 44 patients. It was combined with autologous cancellous bone graft in 38 cases and used alone in a further seven. It was usually employed to fill defects after removal of bone cysts and for long fusions in patients with scoliosis. It was also used to fill bone defects after trauma, for non-union in the lumbosacral area, for anterior vertebral fusions, in limb sparing operations for malignant bone tumours, and in exchange operations after failed joint endoprostheses. We have not seen incompatibility or rejection of the implanted material. The rate of postoperative infection was higher than usual due to the selection of patients, but did not appear to be connected with the use of hydroxyapatite ceramic. We were able to review 36 patients up to sixty months after operation. The results are encouraging with no difference in progress compared with patients in whom simple autologous bone grafts had been used.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2177732     DOI: 10.1007/BF00178768

Source DB:  PubMed          Journal:  Int Orthop        ISSN: 0341-2695            Impact factor:   3.075


  11 in total

1.  A pilot study of the value of ceramics for bone replacement.

Authors:  H Waisbrod; H U Gerbershagen
Journal:  Arch Orthop Trauma Surg       Date:  1986

2.  [Biomaterials and their application to implantation].

Authors:  J F Osborn
Journal:  SSO Schweiz Monatsschr Zahnheilkd       Date:  1979-11

3.  [Experimental studies on bone transplantation with unchanged and denaturated bone substance. A contribution on causal osteogenesis].

Authors:  L Schweiberer
Journal:  Hefte Unfallheilkd       Date:  1970

4.  [Hydroxylapatite ceramics--a bone-like biomaterial. Preliminary report].

Authors:  J F Osborn; T Weiss
Journal:  SSO Schweiz Monatsschr Zahnheilkd       Date:  1978-10

Review 5.  Bone and cartilage transplantation in orthopaedic surgery. A review.

Authors:  K L Brown; R L Cruess
Journal:  J Bone Joint Surg Am       Date:  1982-02       Impact factor: 5.284

6.  [Hydroxylapatite ceramics--development of a new biomaterial and 1st animal experimental results].

Authors:  J F Osborn; E Kovacs; A Kallenberger
Journal:  Dtsch Zahnarztl Z       Date:  1980-01

7.  Spine deformity in neurofibromatosis. A review of one hundred and two patients.

Authors:  R B Winter; J H Moe; D S Bradford; J E Lonstein; C V Pedras; A H Weber
Journal:  J Bone Joint Surg Am       Date:  1979-07       Impact factor: 5.284

8.  Curettage of benign lesions of bone. Factors related to recurrence.

Authors:  A Kreicbergs; P A Lönnqvist; B Nilsson
Journal:  Int Orthop       Date:  1985       Impact factor: 3.075

9.  Neurofibromatous scoliosis. Natural history and results of treatment in thirty-seven cases.

Authors:  J H Chaglassian; E J Riseborough; J E Hall
Journal:  J Bone Joint Surg Am       Date:  1976-07       Impact factor: 5.284

10.  Dystrophic spinal deformities in neurofibromatosis. Treatment by anterior and posterior fusion.

Authors:  L C Hsu; P C Lee; J C Leong
Journal:  J Bone Joint Surg Br       Date:  1984-08
View more
  16 in total

1.  Dynamic fatigue and degradation in solution of hydroxyapatite ceramics.

Authors:  S Raynaud; E Champion; D Bernache-Assolant; D Tetard
Journal:  J Mater Sci Mater Med       Date:  1998-04       Impact factor: 3.896

2.  Nano-hydroxyapatite/poly(L-lactic acid) composite synthesized by a modified in situ precipitation: preparation and properties.

Authors:  C Y Zhang; H Lu; Z Zhuang; X P Wang; Q F Fang
Journal:  J Mater Sci Mater Med       Date:  2010-10-02       Impact factor: 3.896

3.  Coralline hydroxyapatite reinforced with polylactide fibres in lumbar interbody implantation.

Authors:  P Ylinen; M Raekallio; R Taurio; K Vihtonen; S Vainionpää; E K Partio; P Törmälä; P Rokkanen
Journal:  J Mater Sci Mater Med       Date:  2005-04       Impact factor: 3.896

4.  Preparation and in vivo investigation of artificial cornea made of nano-hydroxyapatite/poly (vinyl alcohol) hydrogel composite.

Authors:  Xu Fenglan; Li Yubao; Yao Xiaoming; Liao Hongbing; Zhang Li
Journal:  J Mater Sci Mater Med       Date:  2007-04       Impact factor: 3.896

Review 5.  An update on bone substitutes for spinal fusion.

Authors:  Masashi Miyazaki; Hiroshi Tsumura; Jeffrey C Wang; Ahmet Alanay
Journal:  Eur Spine J       Date:  2009-03-12       Impact factor: 3.134

6.  Far-red fluorescence gene reporter tomography for determination of placement and viability of cell-based gene therapies.

Authors:  Yujie Lu; Chinmay D Darne; I-Chih Tan; Banghe Zhu; Mary A Hall; Zawaunyka W Lazard; Alan R Davis; Lashan Simpson; Eva M Sevick-Muraca; Elizabeth A Olmsted-Davis
Journal:  Opt Express       Date:  2013-10-07       Impact factor: 3.894

7.  Transplanted xenogenic bone marrow stem cells survive and generate new bone formation in the posterolateral lumbar spine of non-immunosuppressed rabbits.

Authors:  Hyung-Jun Kim; Jong-Beom Park; Jin Kyung Lee; Eun-Young Park; Eun-Ae Park; K Daniel Riew; Seung-Koo Rhee
Journal:  Eur Spine J       Date:  2008-09-25       Impact factor: 3.134

8.  Best one hundred papers of International Orthopaedics: a bibliometric analysis.

Authors:  Andreas F Mavrogenis; Panayiotis D Megaloikonomos; Georgios N Panagopoulos; Cyril Mauffrey; Andrew Quaile; Marius M Scarlat
Journal:  Int Orthop       Date:  2017-01-04       Impact factor: 3.075

9.  Synthesis of macroporous poly(dimethylsiloxane) scaffolds for tissue engineering applications.

Authors:  Eileen Pedraza; Ann-Christina Brady; Christopher A Fraker; Cherie L Stabler
Journal:  J Biomater Sci Polym Ed       Date:  2012-10-31       Impact factor: 3.517

10.  Implantation of canine umbilical cord blood-derived mesenchymal stem cells mixed with beta-tricalcium phosphate enhances osteogenesis in bone defect model dogs.

Authors:  Byung Jun Jang; Ye Eun Byeon; Ji Hey Lim; Hak Hyun Ryu; Wan Hee Kim; Yoshihisa Koyama; Masanori Kikuchi; Kyung Sun Kang; Oh Kyeong Kweon
Journal:  J Vet Sci       Date:  2008-12       Impact factor: 1.672

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.